346 related articles for article (PubMed ID: 25865484)
1. The role of the kynurenine pathway in suicidality in adolescent major depressive disorder.
Bradley KA; Case JA; Khan O; Ricart T; Hanna A; Alonso CM; Gabbay V
Psychiatry Res; 2015 Jun; 227(2-3):206-12. PubMed ID: 25865484
[TBL] [Abstract][Full Text] [Related]
2. The possible role of the kynurenine pathway in adolescent depression with melancholic features.
Gabbay V; Klein RG; Katz Y; Mendoza S; Guttman LE; Alonso CM; Babb JS; Hirsch GS; Liebes L
J Child Psychol Psychiatry; 2010 Aug; 51(8):935-43. PubMed ID: 20406333
[TBL] [Abstract][Full Text] [Related]
3. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide.
Messaoud A; Mensi R; Douki W; Neffati F; Najjar MF; Gobbi G; Valtorta F; Gaha L; Comai S
World J Biol Psychiatry; 2019 Nov; 20(9):703-711. PubMed ID: 29683396
[No Abstract] [Full Text] [Related]
4. The possible role of the kynurenine pathway in anhedonia in adolescents.
Gabbay V; Ely BA; Babb J; Liebes L
J Neural Transm (Vienna); 2012 Feb; 119(2):253-60. PubMed ID: 21786117
[TBL] [Abstract][Full Text] [Related]
5. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.
Sublette ME; Galfalvy HC; Fuchs D; Lapidus M; Grunebaum MF; Oquendo MA; Mann JJ; Postolache TT
Brain Behav Immun; 2011 Aug; 25(6):1272-8. PubMed ID: 21605657
[TBL] [Abstract][Full Text] [Related]
6. Tryptophan and Kynurenine Metabolites: Are They Related to Depression?
Pompili M; Lionetto L; Curto M; Forte A; Erbuto D; Montebovi F; Seretti ME; Berardelli I; Serafini G; Innamorati M; Amore M; Baldessarini RJ; Girardi P; Simmaco M
Neuropsychobiology; 2019; 77(1):23-28. PubMed ID: 30110684
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the Relationship among Cortisol, Pro-inflammatory Cytokines, and the Degradation of Tryptophan into Kynurenine in Patients with Major Depression and Suicidal Behavior.
Messaoud A; Rym M; Wahiba D; Neffati F; Najjar MF; Gobbi G; Manchia M; Valtorta F; Lotfi G; Comai S
Curr Top Med Chem; 2022; 22(25):2119-2125. PubMed ID: 34503408
[TBL] [Abstract][Full Text] [Related]
8. Kynurenine pathway changes in late-life depression.
Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
[TBL] [Abstract][Full Text] [Related]
9. The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.
Gabbay V; Liebes L; Katz Y; Liu S; Mendoza S; Babb JS; Klein RG; Gonen O
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):37-44. PubMed ID: 19778568
[TBL] [Abstract][Full Text] [Related]
10. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
[TBL] [Abstract][Full Text] [Related]
11. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
[TBL] [Abstract][Full Text] [Related]
12. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis.
Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W
Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation.
Hughes MM; Carballedo A; McLoughlin DM; Amico F; Harkin A; Frodl T; Connor TJ
Brain Behav Immun; 2012 Aug; 26(6):979-87. PubMed ID: 22683764
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine pathway changes in late-life depression with memory deficit.
Wu Y; Mai N; Zhong X; Wen Y; Zhou Y; Li H; Shang D; Hu L; Chen X; Chen B; Zhang M; Ning Y
Psychiatry Res; 2018 Nov; 269():45-49. PubMed ID: 30145300
[TBL] [Abstract][Full Text] [Related]
15. A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls.
DeWitt SJ; Bradley KA; Lin N; Yu C; Gabbay V
J Affect Disord; 2018 Feb; 227():752-758. PubMed ID: 29254065
[TBL] [Abstract][Full Text] [Related]
16. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
[TBL] [Abstract][Full Text] [Related]
17. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
[TBL] [Abstract][Full Text] [Related]
18. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
[TBL] [Abstract][Full Text] [Related]
19. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.
Suzuki Y; Suda T; Furuhashi K; Suzuki M; Fujie M; Hahimoto D; Nakamura Y; Inui N; Nakamura H; Chida K
Lung Cancer; 2010 Mar; 67(3):361-5. PubMed ID: 19487045
[TBL] [Abstract][Full Text] [Related]
20. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
